Abstract
The malignant transformation of congenital nevocellular nevi, both large and small, is controversial and presents problems in management. The size of the lesion is taken to indicate potential malignant transformation, but this is an arbitrary scale. A more reliable biological indicator is needed to help predict the lesions at risk. Following the localization of neuron-specific enolase to most cells of the diffuse neuroendocrine system and their neoplasms (including benign and malignant melanocytic lesions), it has been suggested that its level is related to tumor activity. In a prospective trial, the presence of neuron-specific enolase immunoreactivity, its concentration, and gene expression in nevus cells were studied in 31 congenital melanocytic nevi of various sizes (1.5 cm to bathing trunk) using immunocytochemistry, biochemical assay, and in situ hybridization. Twenty-five of the 31 congenital nevi were immunoreactive to neuron-specific enolase antiserum, with stronger immunostaining in the larger lesions. There is an apparent linear relationship between the size of the nevi and the level of neuron-specific enolase (expressed as nanograms per milligram protein). Neuron-specific enolase mRNA was highly expresed in most of large congenital nevi (>15 cm in diameter), as revealed by autoradiography following in situ hybridization. Our results show that neuron-specific enolase and its mRNA are expressed to a greater extent in large congenital nevi compared with smaller lesions. This might prove to be a useful indicator of those lesions at risk of malignant transformation.
Similar content being viewed by others
References
Akoun, G., Scarna, H., Milleron, B., Benichou, M., Herman, D. (1985) Serum neuron specific enolase a marker for disease extent and response to therapy for small cell lung cancer. Chest 87:39–43
Alper, J.C. (1985) Congenital nevi: The controversy rages on. Arch. Dermatol. 121:734–740
Bishop, A.E., Polak, J.M., Facer P., Ferri, G.-L., Marangos, P.J., Pearse, A.G.E. (1982) Neuron specific enolase: A common marker for the endocrine cells and innervation of the gut and pancreas. Gastroenterology 83:902–915
Carimele, D., Torsellini, M., Serrif, F. (1977) Comportamento degli enzimi del metabolismo energetico mel melanoma maligno e nelle lesioni premeanomatose. G. Minerva Dermatol. 112:167–171
Cox, K.H., DeLeon, D.V., Angerer L.M., Angerer, R.C. (1984) Detection of mRNA in sea urchin embryos by in situ hybridization using a symetric RNA probe. Dev. Biol. 101:485–502
Dhillon, A.P., Rode, J. (1982) Patterns of staining for neuron-specific enolase in benign and malignant melanocytic lesions of the skin. Diagn. Histopathol. 5:169–174
Greeley, P.W., Middleton, A.G., Curtin, J.W. (1965) Incidence of malignancy in giant pigmented nevi. Plast. Reconstr. Surg. 36:26
Hamid, Q., Bishop, A.E., Sikri, K.L., Varndell, I.M., Bloom, S.R., Polak, J.M. (1986) Immunocytochemical characteristion of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers. Histopathology 10:119–133
Hamid, Q.A., Wharton, J., Terenghi, G., Hassall, C., Aimi, J., Taylor, K.M., Nakazato, H., Dixon, J., Burnstock, G., Polak, J.M. (1987) Localization of atrial natriuretic peptide mRNA and immunoreactivity in rat heart and human atrial appendage. Proc. Natl. Acad. Sci. U.S.A. 84:6760–6764
Hoefler H., Childers H. Montminy M.R., Lechan R.M., Goodman R.H., Wolfe H.J. (1986) ‘In situ’ hybridization methods for the detection of somatostatin mRNA in tissue sections using antisense RNA probes. Histochem. J. 18:597–604
Huang W.M., Gibson, S.J., Facer, P., Gu, J., Polak, J.M. (1983) Improved section adhesion for immunocytochemistry using high molecular weight polymers ofl-lysine as a slide coating. Histochemistry 77:275–279
Lorentzen, M., Pers, M., Bretteville-Jensen, G. (1977) The incidence of malignant transformation in giant pigmented naevi. Scand. J. Plast. Reconstr. Surg. 71:163
Marangos, P.J., Zis, A.P., Clark, R.L., Goodwin, F.K., (1978) Neuronal, non-neuronal and hybrid forms of enolase in brain in structural, immunological and functional comparisons. Brain Res. 150:117–133
NIH Consensus Development Conference Statement, October 24–26, Washington, D.C. (1984) Precursors to malignant melanoma. J. Am. Acad. Dermatol 10:683–686
Parma, A.M., Marangos, P.J., Goodwin, F.K. (1986) A more sensitive radioimmunoassay for neuron-specific enolase (NSE) suitable for cerebrospinal fluid determinations. J. Neurochem. 36:1093–1096
Penschow, J.D., Haralambidis, J., Darling, P.E., Darby, I.A., Wintour, E.M., Tregear, G.W., Coghlan, J.P. (1987) Hybridization histochemistry. Experientia 43:741–750
Polak, J.M., Marangos, P.J. (1984) Neuron-specific enolase, a marker for neuroendocrine cells. Evolution and Tumour Pathology of the Neuroendocrine System. S. Falkmer, R. Hakanson, F. Sundler (eds). Elsevier, Amsterdam, pp 433–480
Quaba, A.A., Wallace, A.F. (1986) The incidence of malignant melanoma (0 to 15 years of age) arising in “large” congenital nevocellular nevi. Plast. Reconstr. Surg. 78:174–179
Reeve, J.G., Stewart, J., Watson, J.V., Wulfrank, D., Twentyman, P.R., Bleehan, N.M. (1986) Neuron-specific enolase expression in carcinoma of the lung. Br. J. Cancer 53:519–528
Rode J., Dhillon, A.P. (1984). Neurone-specific enolase and S100 protein as possible prognostic indicators in melanoma. Histopathology 8:1041–1052
Royds, J.A., Parson, M.A., Rennie, I.G., Timperley, W.R., and Taylor, C.B. (1982) Enolase isoenzymes in benign and malignant melanocytic lesion. Diagn. Histopathol. 5:175–181
Schmechel D., Marangos, P.J., Brightman, M. (1978) Neuron specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature 276:834–836
Schmechel, D.E., Marangos, P.J., Martin, B.M., Winfield, S., Burkhart, D.S., Roses, A.D., Ginns, E.I. (1987) Localization of neuron specific enolase (NSE) mRNA in human brain. Neurosci. Lett. 76:233–238
Singer, R.H., Lawrence, J.B., Villnave, C. (1986) Optimization of in situ and non-isotopic detection methods. Biotechniques 4:230–250
Sternberger, L.A. (1979) The unlabeled, antibody peroxidase-antiperoxidase (PAP) method. Immunocytochemistry. Wiley, New York, pp 104–169
Tapia, F.J., Polak, J.M., Barbosa, A.J.A., Bloom, S.R., Marangos, P.J., Dermody, C., Pearse, A.G.E. (1981) Neuron-specific enolase is produced by neuroendocrine tumours. Lancet i:808–811
Trozak, D.J., Rowland, W.D., Hu, F. (1975) Metastatic malignant melanoma in prepubertal children. Pediatrics 55:191–197 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hamid, Q.A., Bishop, A.E., Springall, D.R. et al. Neuron-specific enolase and its mRNA are highly expressed in large congenital nevi: A study using immunocytochemistry, biochemical assay, and in situ hybridization. J Mol Neurosci 1, 85–91 (1989). https://doi.org/10.1007/BF02918894
Issue Date:
DOI: https://doi.org/10.1007/BF02918894